Multiple hyperlinks to rcsb

Your request to link to rcsb for Trypsin

1CE5: bovine pancreas beta-trypsin in complex with benzamidine
1D6R: crystal structure of cancer chemopreventive bowman-birk inhibitor in ternary complex with bovine trypsin at 2.3 a resolution. structural basis of janus-faced serine protease inhibitor specificity (10.1006/JMBI.2000.3677 )
1EB2: trypsin inhibitor complex (bpo) (10.1021/JM010944E )
1EJM: crystal structure of the bpti ala16leu mutant in complex with bovine trypsin (10.1006/JMBI.2000.3935 )
1EZX: crystal structure of a serpin:protease complex (10.1038/35038119 )
1F0T: bovine trypsin complexed with rpr131247 (10.1021/JM000940U )
1F0U: bovine trypsin complexed with rpr128515 (10.1021/JM000940U )
1F2S: crystal structure of the complex formed between bovine beta-trypsin and mcti-a, a trypsin inhibitor of squash family at 1.8 a resolution (10.1023/A:1020690931043 )
1G36: trypsin inhibitor complex (10.1016/S0969-2126(00)00551-7 )
1G3B: bovine beta-trypsin bound to meta-amidino schiff base magnesium(ii) chelate (10.1006/JMBI.2000.4303 )
1G3C: bovine beta-trypsin bound to para-amidino schiff base iron(iii) chelate (10.1006/JMBI.2000.4303 )
1G3D: bovine beta-trypsin bound to meta-amidino schiff base copper (ii) chelate (10.1006/JMBI.2000.4303 )
1G3E: bovine beta-trypsin bound to para-amidino schiff-base copper (ii) chelate (10.1006/JMBI.2000.4303 )
1G9I: crystal structure of beta-trysin complex in cyclohexane (10.1016/S0167-4838(00)00299-5 )
1GBT: structure of an acyl-enzyme intermediate during catalysis: (guanidinobenzoyl) trypsin (10.1021/BI00488A022 )
1GHZ: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI0: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI1: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI2: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI3: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI4: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI5: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GI6: a novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site (10.1006/JMBI.2001.4516 )
1GJ6: engineering inhibitors highly selective for the s1 sites of ser190 trypsin-like serine protease drug targets (10.1016/S1074-5521(01)00084-9 )
1HJ9: atomic resolution structures of trypsin provide insight into structural radiation damage (10.1107/S0907444901000646 )
1J8A: crystal structure of benzamidine inhibited bovine pancreatic trypsin at 105k to 1.21a resolution from laboratory source with high number of waters modelled
1JIR: crystal structure of trypsin complex with amylamine in cyclohexane
1JRS: hemiacetal complex between leupeptin and trypsin
1JRT: hemiacetal complex between leupeptin and trypsin
1K1I: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1J: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1L: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1M: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1N: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1O: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1K1P: bovine trypsin-inhibitor complex (10.1006/JMBI.2001.5062 )
1LQE: crystal structure of trypsin in complex with 79. (10.1021/JM0111346 )
1MAX: beta-trypsin phosphonate inhibited (10.1021/BI9520996 )
1MAY: beta-trypsin phosphonate inhibited (10.1021/BI9520996 )
1MTS: factor xa specific inhibitor in complex with bovine trypsin (10.1016/0014-5793(95)01190-P )
1MTU: factor xa specific inhibitor in complex with bovine trypsin (10.1016/0014-5793(95)01190-P )
1MTV: factor xa specific inhibitor in complex with bovine trypsin (10.1016/0014-5793(95)01190-P )
1MTW: factor xa specific inhibitor in complex with bovine trypsin (10.1016/0014-5793(95)01190-P )
1N6X: rip-phasing on bovine trypsin (10.1016/S0969-2126(03)00006-6 )
1N6Y: rip-phasing on bovine trypsin (10.1016/S0969-2126(03)00006-6 )
1NC6: potent, small molecule inhibitors of human mast cell tryptase. anti- asthmatic action of a dipeptide-based transition state analogue containing benzothiazole ketone (10.1021/JM030050P )
1NTP: use of the neutron diffraction h/d exchange technique to determine the conformational dynamics of trypsin
1O2H: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2I: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2J: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2K: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2L: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2M: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2N: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2O: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2P: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2Q: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2R: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2S: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2T: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2U: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2V: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2W: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2X: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2Y: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O2Z: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O30: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O31: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O32: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O33: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O34: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O35: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O36: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O37: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O38: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O39: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3A: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3B: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3C: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3D: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3E: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3F: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3G: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3H: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3I: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3J: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3K: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3L: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3M: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3N: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1O3O: elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors (10.1016/S0022-2836(03)00399-1 )
1OPH: non-covalent complex between alpha-1-pi-pittsburgh and s195a trypsin (10.1074/JBC.M305195200 )
1OX1: crystal structure of the bovine trypsin complex with a synthetic 11 peptide inhibitor
1OYQ: trypsin inhibitor complex (10.1016/S0969-2126(00)00551-7 )
1P2I: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
1P2J: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
1P2K: structural consequences of accommodation of four non- cognate amino-acid residues in the s1 pocket of bovine trypsin and chymotrypsin (10.1016/J.JMB.2003.08.059 )
1PPC: geometry of binding of the benzamidine-and arginine-based inhibitors n-alpha-(2-naphthyl-sulphonyl-glycyl)-dl-p-amidinophenylalanyl- piperidine (napap) and (2r,4r)-4-methyl-1-[n-alpha-(3-methyl-1,2,3,4- tetrahydro-8-quinolinesulphonyl)-l-arginyl]-2-piperidine carboxylic acid (mqpa) to human alpha-thrombin: x-ray crystallographic determination of the napap-trypsin complex and modeling of napap- thrombin and mqpa-thrombin (10.1111/J.1432-1033.1990.TB19320.X )
1PPE: the refined 2.0 angstroms x-ray crystal structure of the complex formed between bovine beta-trypsin and cmti-i, a trypsin inhibitor from squash seeds (cucurbita maxima): topological similarity of the squash seed inhibitors with the carboxypeptidase a inhibitor from potatoes (10.1016/0014-5793(89)80486-7 )
1PPH: geometry of binding of the nalpha-tosylated piperidides of m-amidino-, p-amidino-and p-guanidino phenylalanine to thrombin and trypsin: x- ray crystal structures of their trypsin complexes and modeling of their thrombin complexes (10.1016/0014-5793(91)80033-Y )
1QA0: bovine trypsin 2-aminobenzimidazole complex (10.1107/S0907444999007350 )
1QB1: bovine trypsin with 1-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-6- [3-(4,5-dihydro-1-methyl-1h-imidazol-2-yl)phenoxy]pyridin-4- yl]piperidine-3-carboxylic acid (zk-806974) (10.1107/S0907444999007350 )
1QB6: bovine trypsin 3,3'-[3,5-difluoro-4-methyl-2, 6- pyridinediylbis(oxy)]bis(benzenecarboximidamide) (zk- 805623) complex (10.1107/S0907444999007350 )
1QB9: bovine trypsin 7-[[2-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-9h- carbozol-9-yl] methyl]naphthalene-2-carboximidamide (zk-806450) complex (10.1107/S0907444999007350 )
1QBN: bovine trypsin 2-[amino(imino)methyl]-2-hydroxyphenoxy]-6- [3-(4,5-dihydro-1h-imidazol-2-yl)phenoxy]pyridine-4- carboxylic acid (zk-806688) complex (10.1107/S0907444999007350 )
1QBO: bovine trypsin 7-[[6-[[1-(1-iminoethyl)piperidin-4-yl]oxy]-2-methyl- benzimidazol-1-yl]methyl]naphthalene-2-carboximidamid zk-806711 inhibitor complex (10.1107/S0907444999007350 )
1QCP: crystal structure of the rwj-51084 bovine pancreatic beta- trypsin at 1.8 a (10.1107/S0907444999008732 )
1QL7: factor xa specific inhibitor in complex with bovine trypsin (10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO;2-# )
1QL8: factor xa specific inhibitor in complex with bovine trypsin (10.1002/1439-7633(20020301)3:2/3<246::AID-CBIC246>3.0.CO;2-# )
1RXP: structure of trypsin (orthorhombic) with 1-(4-tert- butylcarbamoyl- piperazine-1-carbonyl)-3-(3-guanidino- propyl)-4-oxo-azetidine-2-carboxylic acid (10.1016/J.BMCL.2004.02.012 )
1S0Q: native bovine pancreatic trypsin
1S0R: bovine pancreatic trypsin inhibited with benzamidine at atomic resolution
1SBW: crystal structure of mung bean inhibitor lysine active fragment complex with bovine beta-trypsin at 1.8a resolution
1SFI: high resolution structure of a potent, cyclic protease inhibitor from sunflower seeds (10.1006/JMBI.1999.2891 )
1SMF: studies on an artificial trypsin inhibitor peptide derived from the mung bean inhibitor
1TAB: structure of the trypsin-binding domain of bowman-birk type protease inhibitor and its interaction with trypsin
1TAW: bovine trypsin complexed to appi
1TGB: crystal structure of bovine trypsinogen at 1.8 angstroms resolution. ii. crystallographic refinement, refined crystal structure and comparison with bovine trypsin (10.1016/S0022-2836(77)80062-4 )
1TGC: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
1TGN: structure of bovine trypsinogen at 1.9 angstroms resolution (10.1021/BI00623A016 )
1TGS: three-dimensional structure of the complex between pancreatic secretory inhibitor (kazal type) and trypsinogen at 1.8 angstroms resolution. structure solution, crystallographic refinement and preliminary structural interpretation (10.1016/0022-2836(82)90550-2 )
1TGT: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
1TIO: high packing density form of bovine beta-trypsin in cyclohexane (10.1016/S0167-4838(98)00226-X )
1TLD: crystal structure of bovine beta-trypsin at 1.5 angstroms resolution in a crystal form with low molecular packing density. active site geometry, ion pairs and solvent structure (10.1016/0022-2836(89)90110-1 )
1TNG: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TNH: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TNI: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TNJ: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TNK: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TNL: prediction of novel serine protease inhibitors (10.1038/NSB1094-735 )
1TPA: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
1TPO: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
1TPP: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
1TPS: atomic structure of the trypsin-a90720a complex: a unified approach to structure and function (10.1016/1074-5521(94)90049-3 )
1TX7: bovine trypsin complexed with p-amidinophenylmethylphosphinic acid (ampa) (10.1016/S0968-0896(01)00259-0 )
1TX8: bovine trypsin complexed with amso (10.1016/J.BMCL.2004.07.054 )
1TYN: atomic structure of the trypsin-cyclotheonamide a complex: lessons for the design of serine protease inhibitors
1UTN: trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements (10.1110/PS.03498604 )
1UTO: trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements (10.1110/PS.03498604 )
1UTP: trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements (10.1110/PS.03498604 )
1UTQ: trypsin specificity as elucidated by lie calculations, x-ray structures and association constant measurements (10.1110/PS.03498604 )
1V2J: benzamidine in complex with bovine trypsin variant x(ssri) bt.c1 (10.1016/J.JMB.2003.11.041 )
1V2K: factor xa specific inhibitor in complex with bovine trypsin variant x(triple.glu)bt.d2 (10.1016/J.JMB.2003.11.041 )
1V2L: benzamidine in complex with bovine trypsin variant x(triple.glu)bt.d1 (10.1016/J.JMB.2003.11.041 )
1V2M: benzamidine in complex with bovine trypsin variant x(triple.glu)bt.a1 (10.1016/J.JMB.2003.11.041 )
1V2N: potent factor xa inhibitor in complex with bovine trypsin variant x(99/175/190)bt (10.1016/J.JMB.2003.11.041 )
1V2O: trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.b4 (10.1016/J.JMB.2003.11.041 )
1V2P: trypsin inhibitor in complex with bovine trypsin variant x(ssyi)bt.a4 (10.1016/J.JMB.2003.11.041 )
1V2Q: trypsin inhibitor in complex with bovine trypsin variant x(sswi)bt.b4 (10.1016/J.JMB.2003.11.041 )
1V2R: trypsin inhibitor in complex with bovine trypsin variant x(ssri)bt.b4 (10.1016/J.JMB.2003.11.041 )
1V2S: benzamidine in complex with bovine trypsin variant x(ssfi.glu)bt.d1 (10.1016/J.JMB.2003.11.041 )
1V2T: trypsin inhibitor in complex with bovine trypsin variant x(ssfi.glu)bt.b4 (10.1016/J.JMB.2003.11.041 )
1V2U: benzamidine in complex with bovine trypsin varinat x(ssai) bt.d1 (10.1016/J.JMB.2003.11.041 )
1V2V: benzamidine in complex with bovine trypsin variant x(ssai) bt.c1 (10.1016/J.JMB.2003.11.041 )
1V2W: trypsin inhibitor in complex with bovine trypsin variant x(ssai)bt.b4 (10.1016/J.JMB.2003.11.041 )
1XUF: trypsin-babim-zn+2, ph 8.2 (10.1038/35422 )
1XUG: trypsin-babim-zn+2, ph 8.2 (10.1038/35422 )
1XUH: trypsin-keto-babim-co+2, ph 8.2 (10.1038/35422 )
1XUI: trypsin-keto-babim, zn+2-free, ph 8.2 (10.1038/35422 )
1XUJ: trypsin-keto-babim-zn+2, ph 8.2 (10.1038/35422 )
1XUK: trypsin-babim-sulfate, ph 5.9 (10.1038/35422 )
1Y3U: trypsin inhibitor complex
1Y3V: trypsin inhibitor complex (10.1002/ANIE.200502302 )
1Y3W: trypsin inhibitor complex (10.1002/ANIE.200502302 )
1Y3X: trypsin inhibitor complex (10.1002/ANIE.200502302 )
1Y3Y: trypsin inhibitor complex (10.1002/ANIE.200502302 )
1Y59: dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant (10.1002/CMDC.200600185 )
1Y5A: dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant (10.1002/CMDC.200600185 )
1Y5B: dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant (10.1002/CMDC.200600185 )
1Y5U: dianhydrosugar-based benzamidine, factor xa specific inhibitor in complex with bovine trypsin mutant (10.1002/CMDC.200600185 )
1YP9: trypsin inhibitor complex (10.1002/ANIE.200502302 )
1YYY: trypsin inhibitors with rigid tripeptidyl aldehydes (10.1021/BI980840E )
1ZR0: crystal structure of kunitz domain 1 of tissue factor pathway inhibitor-2 with bovine trypsin (10.1074/JBC.M504105200 )
1ZZZ: trypsin inhibitors with rigid tripeptidyl aldehydes (10.1021/BI980840E )
2A7H: on the routine use of soft x-rays in macromolecular crystallography, part iii- the optimal data collection wavelength (10.1107/S0907444905021475 )
2AGE: succinyl-aapr-trypsin acyl-enzyme at 1.15 a resolution (10.1073/PNAS.0601910103 )
2AGG: succinyl-aapk-trypsin acyl-enzyme at 1.28 a resolution (10.1073/PNAS.0601910103 )
2AGI: the leupeptin-trypsin covalent complex at 1.14 a resolution (10.1073/PNAS.0601910103 )
2AH4: guanidinobenzoyl-trypsin acyl-enzyme at 1.13 a resolution (10.1073/PNAS.0601910103 )
2AYW: crystal structure of the complex formed between trypsin and a designed synthetic highly potent inhibitor in the presence of benzamidine at 0.97 a resolution (10.1107/S090744490700697X )
2BLV: trypsin before a high dose x-ray "burn" (10.1107/S0907444905019360 )
2BLW: trypsin after a high dose x-ray "burn" (10.1107/S0907444905019360 )
2BTC: bovine trypsin in complex with squash seed inhibitor (cucurbita pepo trypsin inhibitor ii) (10.1107/S090744499801052X )
2BY5: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BY6: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BY7: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BY8: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BY9: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BYA: is radiation damage dependent on the dose-rate used during macromolecular crystallography data collection (10.1107/S0907444905033627 )
2BZA: bovine pancreas beta-trypsin in complex with benzylamine
2CMY: crystal complex between bovine trypsin and veronica hederifolia trypsin inhibitor (10.1074/JBC.M703871200 )
2D8W: structure of hyper-vil-trypsin (10.1107/S0907444905041909 )
2F3C: crystal structure of infestin 1, a kazal-type serineprotease inhibitor, in complex with trypsin (10.1107/S0907444912009067 )
2FI3: crystal structure of a bpti variant (cys14->ser, cys38->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
2FI4: crystal structure of a bpti variant (cys14->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
2FI5: crystal structure of a bpti variant (cys38->ser) in complex with trypsin (10.1016/J.JMB.2008.07.063 )
2FTL: crystal structure of trypsin complexed with bpti at 100k (10.1016/J.JMB.2006.11.003 )
2FTM: crystal structure of trypsin complexed with the bpti variant (tyr35- >gly) (10.1016/J.JMB.2006.11.003 )
2FX4: bovine trypsin bound by 4-piperidinebutyrate to make acylenzyme complex (10.1021/BI060173M )
2FX6: bovine trypsin complexed with 2-aminobenzamidazole (10.1021/BI060173M )
2G55: anomalous substructure of trypsin (p3121) (10.1107/S0907444906055624 )
2G5N: indole-amidine complexes with bovine trypsin
2G5V: indole-amidine complexes with bovine trypsin
2G81: crystal structure of the bowman-birk inhibitor from vigna unguiculata seeds in complex with beta-trypsin at 1.55 angstrons resolution (10.1529/BIOPHYSJ.106.090555 )
2G8T: indole-amidine complexes with bovine trypsin
2ILN: crystal structure of the bowman-birk inhibitor from snail medic seeds in complex with bovine trypsin (10.1016/J.JSB.2006.10.017 )
2J9N: robotically harvested trypsin complexed with benzamidine containing polypeptide mediated crystal contacts (10.1107/S0021889807012149 )
2O9Q: the crystal structure of bovine trypsin complexed with a small inhibition peptide orb2k
2OTV: crystal structure of the complex formed between bovine trypsin and nicotinamide at 1.56 a resolution
2OXS: crystal structure of the trypsin complex with benzamidine at high temperature (35 c)
2PLX: trypsin complexed to a synthetic peptide from veronica hederifolia (10.1074/JBC.M703871200 )
2PTC: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
2PTN: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
2QN5: crystal structure and functional study of the bowman-birk inhibitor from rice bran in complex with bovine trypsin
2QYI: crystal structure of a binary complex between an engineered trypsin inhibitor and bovine trypsin
2TGA: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
2TGD: lack of the transition state stabilization site is a factor in the inactivity of trypsinogen, a serine protease zymogen. structure of dfp inhibited bovine trypsinogen at 2.1 angstroms resolution
2TGP: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
2TGT: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
2TIO: low packing density form of bovine beta-trypsin in cyclohexane (10.1016/S0167-4838(98)00226-X )
2TLD: crystal structure of an engineered subtilisin inhibitor complexed with bovine trypsin (10.1073/PNAS.89.10.4407 )
2TPI: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
2UUY: structure of a tick tryptase inhibitor in complex with bovine trypsin (10.1016/J.JMB.2007.03.011 )
2XTT: bovine trypsin in complex with evolutionary enhanced schistocerca gregaria protease inhibitor 1 (sgpi-1-p02) (10.1074/JBC.M110.161604 )
2ZDK: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZDL: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZDM: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZDN: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZFS: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZFT: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZHD: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZQ1: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
2ZQ2: exploring trypsin s3 pocket (10.1016/J.JMB.2010.11.038 )
3A7T: crystal structure of trypsin complexed with 4-formylbenzimidamide
3A7V: crystal structure of trypsin complexed with 3-formylbenzimidamide
3A7W: crystal structure of trypsin complexed with (e)-4-((tetrahydro-2h- pyran-2-yloxyimino)methyl)benzimidamide (soaking 4hours)
3A7X: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (soaking 45seconds)
3A7Y: crystal structure of trypsin complexed with (e)-4-((1-methylpiperidin- 3-yloxyimino)methyl)benzimidamide (soaking 2hours)
3A7Z: crystal structure of trypsin complexed with (e)-4-((1-methylpiperidin- 4-yloxyimino)methyl)benzimidamide (soaking 3hours)
3A80: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid (soaking 40seconds)
3A81: crystal structure of trypsin complexed with (e)-4-((2- nicotinoylhydrazono)methyl)benzimidamide (soaking 8 hours)
3A82: crystal structure of trypsin complexed with pre-synthesized (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid
3A83: crystal structure of trypsin complexed with pre-synthesized (e)-4-((2- nicotinoylhydrazono)methyl)benzimidamide
3A84: crystal structure of trypsin complexed with(e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (soaking 5 seconds)
3A85: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (soaking 15 seconds)
3A86: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (soaking 30 seconds)
3A87: crystal structure of trypsin complexed with (e)-4-((2- nicotinoylhydrazono)methyl)benzimidamide (soaking 5 minutes)
3A88: crystal structure of trypsin complexed with (e)-4-((2- nicotinoylhydrazono)methyl)benzimidamide (soaking 30 minutes)
3A89: crystal structure of trypsin complexed with (e)-4-((2- nicotinoylhydrazono)methyl)benzimidamide (soaking 4 hours)
3A8A: crystal structure of trypsin complexed with 4-formylbenzimidamide and aniline
3A8B: crystal structure of trypsin complexed with (e)-4-((4- bromophenylimino)methyl)benzimidamide
3A8C: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (soaking with mixture of [(e)-2-(4-carbamimidoylbenzylideneaminooxy)acetic acid] and [(e)-2- (4-carbamimidoylbenzylideneaminooxy)-2-methylpropanoic acid])
3A8D: crystal structure of trypsin complexed with (e)-2-(4- carbamimidoylbenzylideneaminooxy)acetic acid (under aniline-free condition)
3AAS: bovine beta-trypsin bound to meta-guanidino schiff base copper (ii) chelate (10.1016/J.BMC.2010.02.016 )
3AAU: bovine beta-trypsin bound to meta-diguanidino schiff base copper (ii) chelate (10.1016/J.BMC.2010.02.016 )
3AAV: bovine beta-trypsin bound to meta-diamidino schiff base copper (ii) chelate (10.1016/J.BMC.2010.02.016 )
3ATI: crystal structure of trypsin complexed with (3-methoxyphenyl) methanamine (10.1107/S0021889811017717 )
3ATK: crystal structure of trypsin complexed with cycloheptanamine (10.1107/S0021889811017717 )
3ATL: crystal structure of trypsin complexed with benzamidine (10.1107/S0021889811017717 )
3ATM: crystal structure of trypsin complexed with 2-(1h-indol-3-yl) ethanamine (10.1107/S0021889811017717 )
3BTD: the crystal structures of the complexes between the bovine beta- trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
3BTE: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
3BTF: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti. (10.1006/JMBI.1999.2654 )
3BTG: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTH: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTK: the crystal structures of the complexes between bovine beta- trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTM: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTQ: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTT: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3BTW: the crystal structures of the complexes between bovine beta-trypsin and ten p1 variants of bpti (10.1006/JMBI.1999.2654 )
3D65: crystal structure of textilinin-1, a kunitz-type serine protease inhibitor from the australian common brown snake venom, in complex with trypsin
3E8L: the crystal structure of the double-headed arrowhead protease inhibitor a in complex with two trypsins (10.1074/JBC.M109.022095 )
3GY2: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3GY3: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3GY4: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3GY5: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3GY6: a comparative study on the inhibition of bovine beta-trypsin by the bis-benzamidines diminazene and pentamidine (10.1016/J.IJBIOMAC.2010.03.006 )
3GY7: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3GY8: a comparative study on the inhibition of bovine beta-trypsin by bis- benzamidines diminazene and pentamidine by x-ray crystallography and itc (10.1016/J.IJBIOMAC.2010.03.006 )
3I29: crystal structure of a binary complex between an mutant trypsin inhibitor with bovine trypsin (10.1016/J.BBAPAP.2012.04.009 )
3ITI: structure of bovine trypsin with the mad triangle b3c (10.1107/S1744309109036884 )
3LJJ: bovine trypsin in complex with ub-thr 10 (10.1016/J.JMB.2010.11.038 )
3LJO: bovine trypsin in complex with ub-thr 11 (10.1016/J.JMB.2010.11.038 )
3M35: trypsin in complex with the inhibitor 1-[3-(aminomethyl) phenyl]-n-[3-fluoro-2'-(methylsulfonyl)biphenyl-4-yl]-3- (trifluoromethyl)-1h-pyrazole-5-carboxamide (dpc423)
3M7Q: crystal structure of recombinant kunitz type serine protease inhibitor-1 from the caribbean sea anemone stichodactyla helianthus in complex with bovine pancreatic trypsin (10.1016/J.JSB.2012.08.009 )
3MFJ: bovine trypsin at 0.8 a resolution, restrained refinement
3MI4: bovine trypsin at 0.8 a resolution, non-restrained refinement
3NK8: trypsin in complex with fluorine-containing fragment (10.1002/PROT.22836 )
3NKK: trypsin in complex with fluorine containing fragment (10.1002/PROT.22836 )
3OTJ: a crystal structure of trypsin complexed with bpti (bovine pancreatic trypsin inhibitor) by x-ray/neutron joint refinement (10.1107/S0907444910053382 )
3PLB: bovine trypsin variant x(tripleile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PLK: bovine trypsin variant x(tripleile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PLP: bovine trypsin variant x(tripleile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PM3: bovine trypsin variant x(tripleile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PMJ: bovine trypsin variant x(tripleile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PTB: the geometry of the reactive site and of the peptide groups in trypsin, trypsinogen and its complexes with inhibitors
3PTN: on the disordered activation domain in trypsinogen. chemical labelling and low-temperature crystallography
3PWB: bovine trypsin variant x(tripleglu217ile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PWC: bovine trypsin variant x(tripleglu217ile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )
3PYH: bovine trypsin variant x(tripleglu217ile227) in complex with small molecule inhibitor (10.1515/HSZ-2014-0158 )